Covered recipient · General Payments record
ABDALMALIK BIN KHUNAYFIR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2021–2024
$872.70
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.37 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $176.98 | 4 |
| Alexion Pharmaceuticals, Inc. | $67.52 | 2 |
| Biogen, Inc. | $17.88 | 1 |
| Averitas Pharma Inc. | $17.20 | 1 |
| EMD Serono, Inc. | $14.87 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $21.27 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110507322 | CMS |
| Alexion Pharmaceuticals, Inc. | $46.25 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110514026 | CMS |
| Averitas Pharma Inc. | $17.20 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133418557 | CMS |
| Biogen, Inc. | $17.88 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104820174 | CMS |
| EMD Serono, Inc. | $14.87 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120256043 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $13.92 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144511138 | CMS |
| UCB, Inc. | $24.97 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143020137 | CMS |
| UCB, Inc. | $17.02 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143020139 | CMS |
| UCB, Inc. | $22.80 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143020141 | CMS |
| UCB, Inc. | $112.19 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143020143 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.